Placenta
Volume 30, Issue 3 , Pages 263-269 , March 2009

Influx Mechanism of 2′,3′-Dideoxyinosine and Uridine at the Blood–Placenta Barrier

,Accepted 30 November 2008.

References 

  1. Suksomboon N, Poolsup N, Ket-Aim S. Systematic review of the efficacy of antiretroviral therapies for reducing the risk of mother-to-child transmission of HIV infection. J Clin Pharm Ther. 2007;32(3):293–311
  2. Sharpe AH, Hunter JJ, Ruprecht RM, Jaenisch R. Maternal transmission of retroviral disease: transgenic mice as a rapid test system for evaluating perinatal and transplacental antiretroviral therapy. Proc Natl Acad Sci USA. 1988;85(24):9792–9796
  3. Dancis J, Lee JD, Mendoza S, Liebes L. Transfer and metabolism of dideoxyinosine by the perfused human placenta. J Acquir Immune Defic Syndr. 1993;6(1):2–6
  4. Henderson GI, Perez AB, Yang Y, Hamby RL. Schenken RS, Schenker S. Transfer of dideoxyinosine across the human isolated placenta. Br J Clin Pharmacol. 1994;38(3):237–242
  5. Atkinson DE, Robinson NR, Sibley CP. Development of passive permeability characteristics of rat placenta during the last third of gestation. Am J Physiol. 1991;261(6 Pt 2):R1461–R1464
  6. Yao SY, Ng AM, Sundaram M, Cass CE, Baldwin SA, Young JD. Transport of antiviral 3′-deoxy-nucleoside drugs by recombinant human and rat equilibrative, nitrobenzylthioinosine (NBMPR)-insensitive (ENT2) nucleoside transporter proteins produced in Xenopus oocytes. Mol Membr Biol. 2001;18(2):161–167
  7. Ritzel MW, Ng AM, Yao SY, Graham K, Loewen SK, Smith KM, et al. Molecular identification and characterization of novel human and mouse concentrative Na+-nucleoside cotransporter proteins (hCNT3 and mCNT3) broadly selective for purine and pyrimidine nucleosides (system cib). J Biol Chem. 2001;276(4):2914–2927
  8. Wada S, Tsuda M, Sekine T, Kimura M, Kanai Y, Endo H. Rat multispecific organic anion transporter 1(rOAT1) transports zidovudine, acyclovir, and other antiviral nucleoside analogs. J Pharmacol Exp Ther. 2001;294(3):844–849
  9. Nishimura M, Naito S. Tissue-specific mRNA expression profiles of human ATP-binding cassette and solute carrier transporter superfamilies. Drug Metab Pharmacokinet. 2005;20(6):452–477
  10. Leazer TM, Klaassen CD. The presence of xenobiotic transporters in rat placenta. Drug Metab Dispos. 2003;31(2):153–167
  11. Ward JL, Sherali A, Mo ZP, Tse CM. Kinetic and pharmacological properties of cloned human equilibrative nucleoside transporters, ENT1 and ENT2, stably expressed in nucleoside transporter-deficient PK15 cells. Ent2 exhibits a low affinity for guanosine and cytidine but a high affinity for inosine. J Biol Chem. 2000;275(12):8375–8381
  12. Yao SY, Ng AM, Muzyka WR, Griffiths M, Cass CE, Baldwin SA, et al. Molecular cloning and functional characterization of nitrobenzylthioinosine (NBMPR)-sensitive (es) and NBMPR-insensitive (ei) equilibrative nucleoside transporter proteins (rENT1 and rENT2) from rat tissues. J Biol Chem. 1997;272(45):28423–28430
  13. Baldwin SA, Yao SY, Hyde RJ, Ng AM, Foppolo S, Barnes K, et al. Functional characterization of novel human and mouse equilibrative nucleoside transporters (hENT3 and mENT3) located in intracellular membranes. J Biol Chem. 2005;280(16):15880–15887
  14. Engel K, Zhou M, Wang J. Identification and characterization of a novel monoamine transporter in the human brain. J Biol Chem. 2004;279(48):50042–50049
  15. Barros LF, Bustamante JC, Yudilevich DL, Jarvis SM. Adenosine transport and nitrobenzylthioinosine binding in human placental membrane vesicles from brush-border and basal sides of the trophoblast. J Membr Biol. 1991;119(2):151–161
  16. Barros LF, Yudilevich DL, Jarvis SM, Beaumont N, Young JD, Baldwin SA. Immunolocalisation of nucleoside transporters in human placental trophoblast and endothelial cells: evidence for multiple transporter isoforms. Pflugers Arch. 1995;429(3):394–399
  17. Govindarajan R, Bakken AH, Hudkins KL, Lai Y, Casado FJ, Pastor-Anglada M, et al. In situ hybridization and immunolocalization of concentrative and equilibrative nucleoside transporters in the human intestine, liver, kidneys, and placenta. Am J Physiol Regul Integr Comp Physiol. 2007;293(5):R1809–R1822
  18. Wang J, Su SF, Dresser MJ, Schaner ME, Washington CB, Giacomini KM. Na+-dependent purine nucleoside transporter from human kidney: cloning and functional characterization. Am J Physiol. 1997;273(6 Pt 2):F1058–F1065
  19. Ritzel MW, Yao SY, Ng AM, Mackey JR, Cass CE, Young JD. Molecular cloning, functional expression and chromosomal localization of a cDNA encoding a human Na+/nucleoside cotransporter (hCNT2) selective for purine nucleosides and uridine. Mol Membr Biol. 1998;15(4):203–211
  20. Kitano T, Iizasa H, Terasaki T, Asashima T, Matsunaga N, Utoguchi N, et al. Polarized glucose transporters and mRNA expression properties in newly developed rat syncytiotrophoblast cell lines, TR-TBTs. J Cell Physiol. 2002;193(2):208–218
  21. Kitano T, Iizasa H, Hwang IW, Hirose Y, Morita T, Maeda T, et al. Conditionally immortalized syncytiotrophoblast cell lines as new tools for study of the blood–placenta barrier. Biol Pharm Bull. 2004;27(6):753–759
  22. Han VK, Bassett N, Walton J, Challis JR. The expression of insulin-like growth factor (IGF) and IGF-binding protein (IGFBP) genes in the human placenta and membranes: evidence for IGF-IGFBP interactions at the feto-maternal interface. J Clin Endocrinol Metab. 1996;81(7):2680–2693
  23. Shin BC, Suzuki T, Matsuzaki T, Tanaka S, Kuraoka A, Shibata Y, et al. Immunolocalization of GLUT1 and connexin 26 in the rat placenta. Cell Tissue Res. 1996;285(1):83–89
  24. Shin BC, Fujikura K, Suzuki T, Tanaka S, Takata K. Glucose transporter GLUT3 in the rat placental barrier: a possible machinery for the transplacental transfer of glucose. Endocrinology. 1997;138(9):3997–4004
  25. Chishu T, Sai Y, Nishimura T, Sato K, Kose N, Nakashima E. Potential of various drugs to inhibit nucleoside uptake in rat syncytiotrophoblast cell line, TR-TBT 18d-1. Placenta. 2008;29(5):461–467
  26. Sai Y, Nishimura T, Shimpo S, Chishu T, Sato K, Kose N, et al. Characterization of the mechanism of zidovudine uptake by rat conditionally immortalized syncytiotrophoblast cell line TR-TBT. Pharm Res. 2008;25(7):1647–1653
  27. Acevedo CG, Rojas S, Ramirez M, Bravo I. Transport and metabolism of adenosine in the perfused human placenta. Placenta. 1995;16(7):611–622
  28. Tamai I, Nezu J, Uchino H, Sai Y, Oku A, Shimane M, et al. Molecular identification and characterization of novel members of the human organic anion transporter (OATP) family. Biochem Biophys Res Commun. 2000;273(1):251–260
  29. Kato R, Maeda T, Akaike T, Tamai I. Nucleoside transport at the blood-testis barrier studied with primary-cultured sertoli cells. J Pharmacol Exp Ther. 2005;312(2):601–608
  30. Takasawa K, Terasaki T, Suzuki H, Sugiyama Y. In vivo evidence for carrier-mediated efflux transport of 3′-azido-3′-deoxythymidine and 2′,3′-dideoxyinosine across the blood-brain barrier via a probenecid-sensitive transport system. J Pharmacol Exp Ther. 1997;281(1):369–375
  31. Gibbs JE, Jayabalan P, Thomas SA. Mechanisms by which 2′,3′-dideoxyinosine (ddI) crosses the guinea-pig CNS barriers; relevance to HIV therapy. J Neurochem. 2003;84(4):725–734
  32. Owen RP, Lagpacan LL, Taylor TR, De La Cruz M, Huang CC, Kawamoto M, et al. Functional characterization and haplotype analysis of polymorphisms in the human equilibrative nucleoside transporter, ENT2. Drug Metab Dispos. 2006;34(1):12–15
  33. Kong W, Engel K, Wang J. Mammalian nucleoside transporters. Curr Drug Metab. 2004;5(1):63–84
  34. Pastor-Anglada M, Cano-Soldado P, Molina-Arcas M, Lostao MP, Larráyoz I, Martínez-Picado J, et al. Cell entry and export of nucleoside analogues. Virus Res. 2005;107(2):151–164
  35. Nishimura T, Seki Y, Sato K, Chishu T, Kose N, Terasaki T, et al. Enhanced uptake of zidovudine with dehydroepiandrosterone sulfate in rat syncytiotrophoblast cell line TR-TBT 18d-1. Drug Metab Dispos. 2008;36(10):2080–2085

PII: S0143-4004(08)00397-4

doi: 10.1016/j.placenta.2008.11.022

Placenta
Volume 30, Issue 3 , Pages 263-269 , March 2009